Literature DB >> 34140398

Patients with High Priority for Kidney Transplant Who Are Not Given Expedited Placement on the Transplant Waiting List Represent Lost Opportunities.

Jesse D Schold1,2, Anne M Huml3, Emilio D Poggio3, John R Sedor3,4, Syed A Husain5,6, Kristin L King5,6, Sumit Mohan5,6.   

Abstract

BACKGROUND: Kidney transplantation is associated with the best outcomes for most patients with ESKD. The national Kidney Allocation System prioritizes patients with Estimated Post-Transplant Survival (EPTS) scores in the top 20% for expedited access to optimal deceased donor kidneys.
METHODS: We studied adults aged ≥18 years in the United States Renal Data System with top 20% EPTS scores who had been preemptively waitlisted or initiated dialysis in 2015-2017. We evaluated time to waitlist placement, transplantation, and mortality with unadjusted and multivariable survival models.
RESULTS: Of 42,445 patients with top 20% EPTS scores (mean age, 38.0 years; 57% male; 59% White patients, and 31% Black patients), 7922 were preemptively waitlisted. Among 34,523 patients initiating dialysis, the 3-year cumulative waitlist placement incidence was 37%. Numerous factors independently associated with waitlisting included race, income, and having noncommercial insurance. For example, waitlisting was less likely for Black versus White patients, and for patients in the lowest-income neighborhoods versus those in the highest-income neighborhoods. Among patients initiating dialysis, 61% lost their top 20% EPTS status within 30 months versus 18% of patients who were preemptively listed. The 3-year incidence of deceased and living donor transplantation was 5% and 6%, respectively, for patients who initiated dialysis and 26% and 44%, respectively, for patients who were preemptively listed.
CONCLUSIONS: Many patients with ESKDqualifying with top 20% EPTS status are not placed on the transplant waiting list in a timely manner, with significant variation on the basis of demographic and social factors. Patients who are preemptively listed are more likely to receive benefits of top 20% EPTS status. Efforts to expedite care for qualifying candidates are needed, and automated transplant referral for patients with the best prognoses should be considered.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  epidemiology and outcomes; kidney transplantation; transplantation

Year:  2021        PMID: 34140398      PMCID: PMC8425662          DOI: 10.1681/ASN.2020081146

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   14.978


  30 in total

1.  Predialysis nephrologist care and access to kidney transplantation in the United States.

Authors:  W C Winkelmayer; J Mehta; A Chandraker; W F Owen; J Avorn
Journal:  Am J Transplant       Date:  2007-04       Impact factor: 8.086

2.  The kidney allocation system.

Authors:  John J Friedewald; Ciara J Samana; Bertram L Kasiske; Ajay K Israni; Darren Stewart; Wida Cherikh; Richard N Formica
Journal:  Surg Clin North Am       Date:  2013-12       Impact factor: 2.741

3.  Quality of Life Is Improved in Renal Transplant Recipients Versus That Shown in Patients With Chronic Kidney Disease With or Without Dialysis.

Authors:  M Masud Iqbal; Naimur Rahman; Morshed Alam; Palash Kumar Deb Nath; Shahryar Waheed; Kamrul Islam; Rana Mokarram Hossain; Ayub Ali Chowdhury
Journal:  Exp Clin Transplant       Date:  2020-01       Impact factor: 0.945

4.  Perspectives on the Strengths and Weaknesses of the National Kidney Allocation System.

Authors:  Richard N Formica
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-21       Impact factor: 8.237

5.  Geographic disparity in kidney transplantation under KAS.

Authors:  Sheng Zhou; Allan B Massie; Xun Luo; Jessica M Ruck; Eric K H Chow; Mary G Bowring; Sunjae Bae; Dorry L Segev; Sommer E Gentry
Journal:  Am J Transplant       Date:  2018-01-27       Impact factor: 8.086

Review 6.  Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.

Authors:  Juan Jesus Carrero; Manfred Hecking; Nicholas C Chesnaye; Kitty J Jager
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

7.  Impact of quality improvement efforts on race and sex disparities in hemodialysis.

Authors:  Ashwini R Sehgal
Journal:  JAMA       Date:  2003-02-26       Impact factor: 56.272

8.  The survival benefit of kidney transplantation in obese patients.

Authors:  J S Gill; J Lan; J Dong; C Rose; E Hendren; O Johnston; J Gill
Journal:  Am J Transplant       Date:  2013-08       Impact factor: 8.086

9.  Geographic variability in access to primary kidney transplantation in the United States, 1996-2005.

Authors:  V B Ashby; J D Kalbfleisch; R A Wolfe; M J Lin; F K Port; A B Leichtman
Journal:  Am J Transplant       Date:  2007       Impact factor: 8.086

10.  An opt-out model for kidney transplant referral: The time has come.

Authors:  Anne M Huml; John R Sedor; Emilio Poggio; Rachel E Patzer; Jesse D Schold
Journal:  Am J Transplant       Date:  2020-07-05       Impact factor: 8.086

View more
  4 in total

1.  Kidney Health Disparities: The Goal is Elimination.

Authors:  Donald E Wesson
Journal:  J Am Soc Nephrol       Date:  2022-06-21       Impact factor: 14.978

2.  Access to kidney transplantation among pediatric candidates with prior solid organ transplants in the United States.

Authors:  Syed Ali Husain; Kristen L King; Nina L Owen-Simon; Hilda E Fernandez; Lloyd E Ratner; Sumit Mohan
Journal:  Pediatr Transplant       Date:  2022-05-26

3.  Keys to Driving Implementation of the New Kidney Care Models.

Authors:  Abhijit V Kshirsagar; Daniel E Weiner; Mallika L Mendu; Frank Liu; Susie Q Lew; Terrence J O'Neil; Scott D Bieber; David L White; Jonathan Zimmerman; Sumit Mohan
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-14       Impact factor: 10.614

4.  Primacy in Kidney Allocation: Does It Alleviate the Barriers to Transplantation?

Authors:  John S Gill; Catherine R Butler; Neil R Powe
Journal:  J Am Soc Nephrol       Date:  2021-06-17       Impact factor: 14.978

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.